compound glp-1 ban Fifth Circuit probes FDA on compounded GLP-1s FDA Ban on Compounded GLP-1

Interview Courtesy | Ankit Kankar #GLP1 #Diabetes #Obesity #Cardiology #Metabolism #Therapeutics #Innovation #Healthcare #Medicine #Research #Pharmacology #Biotechnology #Clinicaltrials #Prevention #Wellness

This local paracrine GLP-1 signalling seems to be specifically involved in the perception of sweets

GLP-1 RAs mimic naturally occurring GLP-1, an enterohormone produced in response to oral intake that regulates glucose metabolism and promotes weight loss

By modulating TGF-1 in conjunction with other inflammatory pathways like PI3K/AKT and NF-B, regulating the oxidant/antioxidant balance, and improving the integrity of the intestinal barrier, Dula prevented AA-induced colitis in rats.

While their glycemic, weight-lowering, and cardiovascular benefits are well established through randomized trials and meta-analyses, concerns remain regarding their safety and tolerability across diverse populations and clinical settings